Fri, Apr. 22, 9:00 AM
- Kimberly-Clark (NYSE:KMB) reports organic sales rose 2% in Q1, due to higher volumes.
- Developing and emerging markets increased 5% for the period.
- Foreign currency exchange rates negatively impacted revenue by 7%.
- Segment revenue: Personal care: $2.207B (-4.4%); Consumer Tissue: $1.496B (-5%); K-C Professional: $763M (-4%).
- Adjusted gross margin rate improved 100 bps to 36.6%.
- Segment operating profit: Personal care: $449M (-1.3%); Consumer Tissue: $280M (-3.8%); K-C Professional: $150M (+11.9%).
- Adjusted operating margin rate expanded 90 bps to 18.3%.
- FY2016 Guidance: Organic sales growth: 3% to 5%; Tax rate: 30.5% to 32.5%; Adjusted EPS: $5.95 to $6.15; Diluted EPS: $5.89 to $6.12.
- KMB -4.14% premarket.
Mon, Jan. 25, 8:06 AM
- Kimberly-Clark (NYSE:KMB) reports organic sales increased 1% in Q4.
- Net sales were down in all the company's segments as F/X pressure took a toll.
- Operating profit by segment: Personal Care +15% to $473M, Consumer Tissue -6% to $262M, K-C Professional +4% to $157M.
- The company expects 2016 EPS of $5.95 to $6.15 vs. $6.14 consensus.
- Previously: Kimberly-Clark misses by $0.01, misses on revenue (Jan. 25 2016)
- KMB -5.15% premarket to $120.20.
Tue, Jan. 5, 3:02 PM
- Kimberly-Clark (KMB +2.2%) recorded a new all-time high today as it broke over $130.
- The stock has easily outperformed broad market averages over the last year, while leaving larger rival Procter & Gamble in the dust. Over the last five years, KMB has made a slow uphill climb without nearly as many nervy dips as other multinationals.
- Kimberly-Clark is due to report Q4 earnings on January 22 with analysts expecting the company to report revenue of $4.582B and EPS of $1.43.
Jul. 23, 2015, 8:55 AM
- Underneath the hood, Kimberly-Clark (NYSE:KMB) showed some strong demand trends in Q2.
- Organic sales were up 4% during the period with a 10% jump in developing and emerging markets.
- F/X cut into top-line sales by 10%.
- Volume in both the personal care segment consumers tissue segments rose 3%.
- Guidance: The company expects EPS of $5.65-$5.80 vs. $5.60-$5.80 prior and $5.73 consensus.
- Previously: Kimberly-Clark beats by $0.05, revenue in-line
- KMB +0.40% premarket to $112.65.
Jan. 23, 2015, 8:27 AM
- Kimberly-Clark (NYSE:KMB) reports organic sales growth of 3% in Q4.
- Segment revenue: Personal care: $2.34B (-1.3%); Consumer Tissue: $1.62B (-2.82%); K-C Professional: $857M (+1.3%).
- Segment operating profit: Personal care: $410M (+3.02%); Consumer Tissue: $280M (+1.82%); K-C Professional: $151M (+2.03%).
- FY2015 Guidance: Organic sales growth: 3% to 5%; Volume : +2% to +3%; Adjusted operating profit: +1% to +4%; Tax rate: 31.5% to 33.5%; Adjusted EPS: $5.60 to $5.80 (+2% to +5%); Capital expenditure: $950M to $1.05B.
- KMB -4.04% premarket.
Dec. 23, 2014, 9:35 AM
Oct. 21, 2014, 9:18 AM
- Kimberly-Clark (NYSE:KMB) announces it will restructure itself in order to improve efficiency following the spinoff of its health care operation.
- The company's workforce will be reduced by 1,100 to 1,300 employees.
- Total costs for the restructuring are pegged at $130M-$160M.
- The action is expected to deliver pre-tax savings of $120M-$140M by the end of 2017.
- Previous: Q3 results, highlights.
- KMB +0.9% premarket.
Jul. 28, 2014, 3:31 PM
- A number of consumer goods companies that sell widely to retail chains are under-performing market indexes today after Dollar Tree announced it will buy out Family Dollar.
- Consolidation in the retail sector could give some leverage to the store chains as their scale broadens, according to Belus Capital Advisors' Brian Sozzi.
- On watch: PepsiCo (PEP -0.7%), Coca-Cola (KO -0.7%), Kraft Foods (KRFT -0.1%), Procter & Gamble (PG -0.4%), Colgate-Palmolive (CL -0.3%), Energizer Holdings (ENR -0.8%), Kimberly-Clark (KMB -0.3%).
- Related ETFs: XLP, VDC, FXG, IYK, RHS, FSTA, UGE, SZK
Jul. 14, 2014, 5:37 PM
Apr. 21, 2014, 9:14 AM
Jan. 24, 2014, 7:42 AM
- Organic sales rose 5% during Q4 for Kimberly-Clark (KMB) as new product innovations contributed.
- The company saw volume gains of 4% and higher selling prices of 1% during the period.
- Sales in K-C International were up 5% despite a tough foreign exchange atmosphere, while lower selling prices in North America kept sales growth flat.
- KMB +1.1% premarket
Dec. 6, 2013, 10:03 AM
- Consumer staples stocks are getting some run out of a positive read on consumer sentiment and an improvement in the unemployment rate in the U.S. The group is outpacing broader market averages in early action.
- Advancers: Clorox (CLX) +2.2%, Procter & Gamble (PG) +2.0%, Energizer (ENR) +1.9%, Unilever (UL) +1.3%, Colgate-Palmolive (CL) +1.3%, Kimberly Clark (KMB) +1.1%, Avon Products (AVP) +1.0%.
- Related ETFs: XLP, VDC, FXG, RHS, PSL, PSCC, FSTA
Nov. 14, 2013, 4:29 PM
- A spin-off, says the company, would create a stand-alone, publicly traded firm with about $1.6B in annual sales. The unit's "strategic fit and growth priorities have changed over time and we now think that pursuing a spin-off makes sense for our shareholders," says CEO Thomas Falk.
- Robert E. Abernathy, currently Kimberly-Clark Group President Europe, Global Nonwovens, and Continuous Improvement and Sustainability, will be CEO of the new company.
- Management hopes to execute the spin-off by the end of 2014 Q3. It's expected to be in the form of a tax-free distribution of the new company's common stock to KMB shareholders.
- CC tomorrow at 10 ET.
- KMB +4.3% AH.
Apr. 24, 2013, 10:48 AM
The rough patch hit by Procter & Gamble in emerging markets isn't giving unnoticed by some of its peers with Kimberly-Clark (KMB -1.2%), Colgate-Palmolive (CL -1.7%), and Clorox (CLX -1.5%) all showing weakness. ETF watch: Is the frothy run of consumer staple ETFs (XLP, FXG, VDC) at risk of running out of steam as sector rotation picks up?| Apr. 24, 2013, 10:48 AM | 2 Comments
Apr. 19, 2013, 7:49 AM
More on Kimberly-Clark (KMB) Q1 earnings: FY2013 EPS guidance upped to $5.60-$5.75 vs. $5.50-$5.65 previously. Organic sales up 3% Y/Y, but revenue gain of just 1%, mostly thanks to currency moves. Operating profit gained 16% thanks to a 200 bp boost to margins. Completed $800M in share repurchases. Shares +3.6% premarket. (PR)| Apr. 19, 2013, 7:49 AM
Apr. 5, 2013, 7:45 AM